Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia

ClinicalTrials.gov ID: NCT00696787

Public ClinicalTrials.gov record NCT00696787. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 1:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pregabalin-Referenced, Parallel-Group, Adaptive Design Study of DVS SR in Adult Female Outpatients With Fibromyalgia Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate if DVS SR is safe and effective in the treatment of pain associated with fibromyalgia syndrome, and if so to identify the efficacious doses.

Study identification

NCT ID
NCT00696787
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
125 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2008 (Type not available)
Primary completion
Jan 2009 (Actual)
Completion
Jan 2009 (Actual)
Last update posted
Feb 25, 2013

2008 – 2009

United States locations

U.S. sites
27
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801 —
Not listed Roseville California 95661 —
Not listed San Diego California 92108 —
Not listed San Diego California 92128 —
Not listed Santa Ana California 92705 —
Not listed Walnut Creek California 94598 —
Not listed Jacksonville Florida 32216 —
Not listed Tampa Florida 33606 —
Not listed Decatur Georgia 30033 —
Not listed Evansville Indiana 47714 —
Not listed Indianapolis Indiana 46260 —
Not listed Lexington Kentucky 40509 —
Not listed Rockville Maryland 20852 —
Not listed Lansing Michigan 48910 —
Not listed Raleigh North Carolina 27612 —
Not listed Cincinnati Ohio 45219 —
Not listed Dayton Ohio 45408 —
Not listed Duncansville Pennsylvania 16635 —
Not listed Philadelphia Pennsylvania 19152 —
Not listed Chattanooga Tennessee 37404 —
Not listed Chattanooga Tennessee 37421 —
Not listed Knoxville Tennessee 37920 —
Not listed Austin Texas 78756 —
Not listed Dallas Texas 75231 —
Not listed San Antonio Texas 78205 —
Not listed Salt Lake City Utah 84102 —
Not listed Middleton Wisconsin 53562 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00696787, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 25, 2013 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00696787 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →